Quelltext anzeigen

Du bist nicht berechtigt, die Seite zu bearbeiten. Grund:

Du kannst den Quelltext dieser Seite betrachten und kopieren:

{{up|PHA pharmacophore by screened target}} {{tp|p=32532959|t=2020. The role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the presence or absence of trypsin.|pdf=|usr=009}} {{tp|p=32821033|t=2020. SARS-CoV-2 growth, furin-cleavage-site adaptation and neutralization using serum from acutely infected hospitalized COVID-19 patients.|pdf=|usr=018}} {{tp|p=32964551|t=2020. Aframomum melegueta secondary metabolites exhibit polypharmacology against SARS-CoV-2 drug targets: in vitro validation of furin inhibition.|pdf=|usr=020}} {{tp|p=33007239|t=2020. Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects.|pdf=|usr=019}} {{tp|p=33043282|t=2020. Furin: A Potential Therapeutic Target for COVID-19.|pdf=|usr=020}} {{tp|p=33169107|t=2020. Synergy of melanin and vitamin-D may play a fundamental role in preventing SARS-CoV-2 infections and halt COVID-19 by inactivating furin protease.|pdf=|usr=020}}

Zurück zur Seite PHA SCR spike protein Furin.